Gary W. Miller

Active 1973–2025

124
Papers
23,301
Citations
77
h-index
122
i10-index

Citations

Citations per year for Gary W. Miller1951: 1 citations1974: 6 citations1975: 6 citations1976: 5 citations1977: 5 citations1978: 4 citations1979: 2 citations1980: 7 citations1981: 1 citations1982: 3 citations1983: 3 citations1984: 3 citations1985: 2 citations1986: 2 citations1987: 2 citations1988: 3 citations1989: 2 citations1990: 2 citations1991: 1 citations1992: 2 citations1994: 1 citations1995: 1 citations1996: 1 citations1997: 2 citations1998: 16 citations1999: 60 citations2000: 69 citations2001: 66 citations2002: 85 citations2003: 113 citations2004: 133 citations2005: 113 citations2006: 140 citations2007: 162 citations2008: 156 citations2009: 164 citations2010: 142 citations2011: 200 citations2012: 132 citations2013: 177 citations2014: 162 citations2015: 135 citations2016: 152 citations2017: 138 citations2018: 109 citations2019: 457 citations2020: 616 citations2021: 843 citations2022: 880 citations2023: 749 citations2024: 1,251 citations2025: 667 citations2026: 25 citations1952–1973: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,946 citing papers, 28.3% of this breakdownChina: 1,046 citing papers, 10% of this breakdownUnited Kingdom: 527 citing papers, 5% of this breakdownItaly: 476 citing papers, 4.6% of this breakdownGermany: 458 citing papers, 4.4% of this breakdownCanada: 330 citing papers, 3.2% of this breakdownSpain: 315 citing papers, 3% of this breakdownFrance: 299 citing papers, 2.9% of this breakdownIndia: 297 citing papers, 2.8% of this breakdownAustralia: 270 citing papers, 2.6% of this breakdownNetherlands: 222 citing papers, 2.1% of this breakdownJapan: 215 citing papers, 2.1% of this breakdown
0%28.3%Other 29%

Fields

  • Medicine37.9%
  • Biochemistry, Genetics and Molecular Biology19.5%
  • Neuroscience17.9%
  • Environmental Science7.9%
  • Immunology and Microbiology3.5%
  • Agricultural and Biological Sciences3.1%
  • Other10.2%

Topics

  • Parkinson's Disease Mechanisms and Treatments6%
  • Neuroscience and Neuropharmacology Research2.9%
  • Neurotransmitter Receptor Influence on Behavior2.8%
  • Nerve injury and regeneration2.1%
  • Health, Environment, Cognitive Aging1.9%
  • Neuroinflammation and Neurodegeneration Mechanisms1.8%
  • Other82.5%

Coauthors

All papers

Open in search
  1. Chronic inflammation in the etiology of disease across the life span

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2019 cited by 4,669

  2. The exposome and health: Where chemistry meets biology

    Authors: , , , - Science 2020 cited by 1,063

  3. Sampling interstitial fluid from human skin using a microneedle patch

    Authors: , , , , , , , , , - Science Translational Medicine 2020 cited by 359

  4. The Nature of Nurture: Refining the Definition of the Exposome

    Authors: , - Toxicological Sciences 2013 cited by 541

  5. Preventing Parkinson’s Disease: An Environmental Agenda

    Authors: , , , , - Journal of Parkinson s Disease 2021 cited by 151

  6. The exposome and liver disease - how environmental factors affect liver health

    Authors: , , , , , , , - Journal of Hepatology 2023 cited by 158

  7. Mechanism of Toxicity in Rotenone Models of Parkinson's Disease

    Authors: , , , , , , , , , - Journal of Neuroscience 2003 cited by 1,079

  8. Metformin rescues Parkinson’s disease phenotypes caused by hyperactive mitochondria

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 159

  9. Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach

    Authors: , , , , , , , , , , , - Environment International 2019 cited by 222

  10. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 676

  11. High-Resolution Mass Spectrometry for Human Exposomics: Expanding Chemical Space Coverage

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hana Seličová, Helge Hecht, Sheng Liu, Hanisha Udhani, Sophie Restituito, Kam-Meng Tchou-Wong, Kun Lü, Jonathan W. Martin, Benedikt Warth, Krystal J. Godri Pollitt, Jana Klánová, Oliver Fiehn, Thomas Metz, Kurt D. Pennell, Dean P. Jones, Gary W. Miller - Environmental Science & Technology 2024 cited by 94

  12. The Exposome: Molecules to Populations

    Authors: , , , , , - The Annual Review of Pharmacology and Toxicology 2018 cited by 243

  13. Towards a comprehensive characterisation of the human internal chemical exposome: Challenges and perspectives

    Authors: , , , , , , , , , , - Environment International 2021 cited by 97

  14. Human Suction Blister Fluid Composition Determined Using High-Resolution Metabolomics

    Authors: , , , , , , - Analytical Chemistry 2018 cited by 97

  15. Assessing the contribution of the chemical exposome to neurodegenerative disease

    Authors: , , , , , , , - Nature Neuroscience 2024 cited by 62

  16. Reference Standardization for Mass Spectrometry and High-resolution Metabolomics Applications to Exposome Research

    Authors: , , , , , , , , , , , - Toxicological Sciences 2015 cited by 247

  17. Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 153

  18. Challenges in IBD Research: Environmental Triggers

    Authors: , , , , , , , , , , , , , , , , , , , - Inflammatory Bowel Diseases 2019 cited by 93

  19. From the exposome to mechanistic understanding of chemical-induced adverse effects

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gerrit Schüürmann, Benno Schwikowski, Yu-Mei Tan, Saskia Trump, Susanne Walter-Rohde, John F. Wambaugh - Environment International 2016 cited by 212

  20. Merging the exposome into an integrated framework for “omics” sciences

    Authors: , , , , , , , , , , - iScience 2022 cited by 66

  21. Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Neuroinflammation 2023 cited by 34

  22. Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons

    Authors: , - Molecular Neurobiology 2009 cited by 201

  23. Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits

    Authors: , , , , , , , , , , , , , , , , - Neurobiology of Disease 2014 cited by 158

  24. The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance

    Authors: , , , - ACS Chemical Neuroscience 2019 cited by 115